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Lower motor neuron dysfunction is one of the most debilitating motor conditions. In this
regard, transgenic mouse models of various lower motor neuron dysfunctions provide
insight into the mechanisms underlying these pathologies and can also aid the development
of new therapies. Viral-mediated gene therapy can take advantage of the muscle-motor
neuron topographical relationship to shuttle therapeutic genes into specific populations
of motor neurons in these mouse models. In this context, motor end plates (MEPs) are
highly specialized regions on the skeletal musculature that offer direct access to the pre-
synaptic nerve terminals, henceforth to the spinal cord motor neurons. The aim of this
study was two-folded. First, it was to characterize the exact position of the MEP regions
for several muscles of the mouse forelimb using acetylcholinesterase histochemistry.This
MEP-muscle map was then used to guide a series of intramuscular injections of Fluoro-
Gold (FG) in order to characterize the distribution of the innervating motor neurons. This
analysis revealed that the MEPs are typically organized in an orthogonal fashion across the
muscle fibers and extends throughout the full width of each muscle. Furthermore, target-
ing the full length of the MEP regions gave rise labeled motor neurons that are organized
into columns spanning through more spinal cord segments than previously reported. The
present analysis suggests that targeting the full width of the muscles’ MEP regions with
FG increases the somatic availability of the tracer. This process ensures a greater uptake
of the tracer by the pre-synaptic nerve terminals, hence maximizing the labeling in spinal
cord motor neurons. This investigation should have positive implications for future studies
involving the somatic delivery of therapeutic genes into motor neurons for the treatment
of various motor dysfunctions.
Keywords: motor end plates, motor neurons, Fluoro-Gold, mouse forelimb, motor neuron columns, retrograde
tracing
INTRODUCTION
Knowledge regarding the organization of the lower motor neuron
system has significantly developed through the work of Sher-
rington (1892), Romanes (1941, 1946, 1951), and Rexed (1954).
Collectively, their work has established that motor neurons in the
ventral horn of the spinal cord that innervate skeletal muscles
are arranged into longitudinal columns. More recently, retrograde
tracers, either applied to the peripheral nerve stump or injected
intramuscularly, have been instrumental in defining the connec-
tivity between individual skeletal muscles and the innervating
motor neuron columns in various mammalian species (Kristens-
son and Olsson, 1971a,b; McHanwell and Biscoe, 1981; Jenny
and Inukai, 1983; Nicolopoulos-Stournaras and Iles, 1983; Brichta
et al., 1987; Callister et al., 1987; Hörner and Kümmel, 1993;
Novikova et al., 1997; Vanderhorst and Holstege, 1997; McKenna
et al., 2000; Choi et al., 2002; Tosolini and Morris, 2012; Bác-
skai et al., 2013a,b). Together, these studies further characterize
the organization of motor neuron columns throughout the spinal
cord.
Dysfunctions or diseases of the lower motor neurons are
amongst the most debilitating motor disorders. In this regard, the
emergence of numerous transgenic mouse models of lower motor
neuron conditions provide insight into the mechanisms under-
lying these pathologies (Gurney et al., 1994; Wong et al., 1995,
2002; Hsieh-Li et al., 2000; Kaspar et al., 2003; Ishiyama et al.,
2004; Turner et al., 2009; Wegorzewska et al., 2009; Kimura et al.,
2010; Towne et al., 2010; Xu et al., 2010; Guo et al., 2011; Riboldi
et al., 2011; Pratt et al., 2013). For example, the Cu/Zn superoxide
dismutase type-1 (SOD-1) mouse model was developed in order
to further understand the etiology and pathogenesis of a subtype
of amyotrophic lateral sclerosis (Gurney et al., 1994; Wong et al.,
1995; Raoul et al., 2005; Zhong et al., 2009; Towne et al., 2010;
Riboldi et al., 2011). This is also the case for the survival motor
neuron 1 (SMN) knockout mouse model of spinal muscular atro-
phy (SMA) (Hsieh-Li et al., 2000). With these mouse models,
viral-mediated gene therapy can take advantage of the muscle-
motor neuron topographical relationship to retrogradely shuttle
therapeutic genes into specific populations of motor neurons (for
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recent reviews, see Bo et al., 2011; Wang et al., 2011; Federici and
Boulis, 2012; Franz et al., 2012; Lentz et al., 2012). This approach
has been explored using intramuscular bolus injections (Baum-
gartner and Shine, 1997, 1998; Kaspar et al., 2003; Nakajima et al.,
2008, 2010; Uchida et al., 2012; Benkhelifa-Ziyyat et al., 2013).
With this gene delivery method, however, the levels of transgene
expression in motor neurons and, therefore, the outcomes of the
therapy often remain suboptimal.
Motor end plates (MEPs) are highly specialized regions on the
skeletal musculature that offer direct access to the pre-synaptic
nerve terminals, henceforth to the spinal cord motor neurons.
We have recently described the location and span of the MEP
regions for several muscles of the rat forelimb (Tosolini and Mor-
ris, 2012). Targeting the entire MEP region with retrograde tracers
has revealed that the motor neuron columns supplying the rat
forelimb span more cervical segments and exhibit greater overlap
with neighbor columns than previously reported (Tosolini and
Morris, 2012). The aim of the present investigation was to extend
this knowledge to the mouse, the species of choice for gene target-
ing in animal models of various motor conditions (Hsieh-Li et al.,
2000; Kaspar et al., 2003; Ishiyama et al., 2004; Turner et al., 2009;
Wegorzewska et al., 2009; Kimura et al., 2010; Towne et al., 2010;
Xu et al., 2010; Guo et al., 2011; Riboldi et al., 2011; Pratt et al.,
2013).
MATERIALS AND METHODS
ANIMALS
All experimental procedures complied with the Animal Care and
Ethics Committee of the University of New South Wales and were
performed in accordance with the National Health and Medical
Research Council of Australia regulations for animal experimen-
tation. A total of 38 adult male C57BL/6 mice (ARC, Western
Australia) weighing between 20 and 30 g at the time of surgery
were used in this study. The mice were housed in groups of five
in an animal holding room under 12-h light–dark cycle. Water
and chow were available ad libitum throughout the course of the
experiment.
ACETYLCHOLINESTERASE HISTOCHEMISTRY
Acetylcholinesterase histochemistry (AChE) was performed on
mice carcasses as per Tosolini and Morris (2012). Six lightly
perfused mice were obtained through tissue sharing. The skin
was removed from the carcasses and the entire bodies were
immersed for 4 h at 4˚C in a solution containing 200 ml of
phosphate buffer (PB), 290 mg acetylthiocholine iodide, 600 mg
glycine, and 420 mg copper sulfate (all reagents from Sigma-
Aldrich, St. Louis, MO, USA). The carcasses were subsequently
washed for 2 min in distilled water and developed by rapid
immersion (i.e., 5–10 s) in a 10% ammonium sulfide solu-
tion.
SURGERY
Anesthesia was induced with isoflurane (Provet, Sydney, NSW,
Australia; 1–2% in O2). The fur covering the targeted areas was
shaved and cleaned with 70% ethanol. For each muscle under
investigation, a small incision was made directly in the skin to
expose the muscle of interest. Fluoro-Gold (FG) (Fluorochrome,
Denver, CO, USA) injections were manually performed through
graded glass micropipettes (DKSH, Zurich, Switzerland) along the
entire MEP region. Great care was taken to preserve the fasciae cov-
ering both the targeted muscles and those in the surrounding. Spe-
cial care was also taken to ensure that the blood vessels surrounding
the muscles were left intact. After the injections, the muscles were
wiped with gauze to remove any tracer that may have inadvertently
seeped from the injected muscle. A total of 47 series of intra-
muscular injections along the full extent of the MEP region were
performed into the following muscles: acromiotrapezius (n= 6),
acromiodeltiodeus (n= 6), spinodeltoideus (n= 5), biceps brachii
(n= 6), triceps brachii (n= 6), extensor carpi ulnaris (n= 4),
extensor carpi radialis (n= 6), flexor carpi ulnaris (n= 4), and
flexor digitorum profundus (n= 4). For these injections, the vol-
ume of FG varied between 2 and 6µl depending on the size
of the muscle (i.e., triceps brachii received 6µl whereas exten-
sor carpi ulnaris received 2µl). Triceps brachii was also targeted
with either a 3-µl bolus injection of FG into the thickest part of
the muscle (n= 6) or with 3µl injections restricted to the ante-
rior or the posterior portion of its MEP (n= 4). In additional
animals, 3µl of FG was applied directly onto the intact fasciae
covering triceps brachii (n= 4). The skin was subsequently closed
with surgical clips (Texas Scientific Instruments LLC, Boerne, TX,
USA).
HISTOLOGICAL PROCESSING AND DISSECTION
After the intramuscular injections of FG, the mice were kept for
7 days to allow for optimal retrograde transport of the neuronal
tracer. After this period of time, the mice received a lethal dose
of Lethabarb (Virbac, Sydney, NSW, Australia) and were intracar-
dially perfused with 0.1 M PB followed by 4% paraformaldehyde in
0.1 M PB. Dissections of the spinal cord were made from the dorsal
aspect whereby the paravertebral muscles were reflected/removed
and the cervical vertebral column was exposed. The bony spin-
ous process of C2 was identified and then removed, exposing
the C2 dorsal roots, which were then colored with a permanent
marker. Vertebrae C3–T1 were subsequently removed one by one
and the dorsal roots were colored in alternating colors (i.e., C2,
C4, C6, and C8 were colored with a green marker and C3, C5,
C7, T1 were colored with a blue marker). After this process, the
cervical spinal cord was cut transversely into two-segment blocks
(i.e., C2–C3, C4–C5, C6–C7, and C8–T1 blocks). For each block,
a fiducial mark was made in situ in the white matter, half way
between two adjacent roots to indicate the boundary between the
segments. The blocks were then removed from the body, post-
fixed overnight in a solution containing 4% paraformaldehyde
in 0.1 M PB and then cryoprotected in a 30% sucrose solu-
tion (Sigma-Aldrich, St. Louis, MO, USA) in distilled water for
2 days at 4˚C. Each block of spinal cord tissue was cut longitu-
dinally in 50µm-thick sections and mounted onto microscope
slides. The slides were air-dried and then coverslipped with an
anti-fade medium containing DAPI (Invitrogen, Carlsbad, CA,
USA).
DATA ANALYSIS AND PRESENTATION
After the AChE procedure, the bodies were photographed, and
Adobe Photoshop CS6 was used to transpose the average locations
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of the MEPs onto a diagrammatic representation of the mouse
forelimb adapted from Komárek (2004) and DeLaurier et al.
(2008).
The spinal cord tissue sections were photographed and ana-
lyzed under epifluorescence to detect FG-labeled motor neurons.
Motor neurons were considered positively labeled when FG gran-
ulations were present within both the soma and at least one
axon/dendrite (Vanderhorst and Holstege, 1997; Tosolini and
Morris, 2012; Bácskai et al., 2013a,b). Adjacent tissue was also
scrutinized to eliminate double counting of motor neurons. For
each tissue section, FG labeled motor neurons were plotted as
single black dots on a separate layer of a diagrammatic repre-
sentation of the spinal cord using Adobe Photoshop CS6. Root
exit points, the position of the central canal and the fiducial
marks created during dissection were used as spatial references.
The Adobe Photoshop layers were subsequently stacked together
to create a single two-dimensional representation of the posi-
tion of the motor neurons innervating each forelimb muscle. For
each muscle, individual data plots were then presented side by
side on a schematic diagram of a spinal cord (Figure 3). The
data plots derived from intramuscular injections performed on
the left forelimb were transposed onto the right spinal cord to
maintain consistency with the representation. For all muscles,
data plots were then combined to form a representative motor
neuron column and were represented concurrently in rostro-
caudal, dorso-ventral, and medio-lateral axes in the same figure
(Figure 5).
RESULTS
MOTOR END PLATE DELINEATION
Overall, for each muscle the location of the MEP region was simi-
lar between animals. The location and span of the MEPs for each
muscle investigated is shown in Figure 1. Figure 1A is a pho-
tograph showing the lateral view of a mouse forelimb after an
AChE reaction. The MEPs can be seen as black speckles travers-
ing the muscle fibers. On this photograph, the boundaries of each
muscle as well as the direction of their muscle fibers can also be
observed, allowing for in situ muscle orientation. Figures 1B,C
are schematic representations of the lateral and medial forelimb
on which the location of the MEPs were transposed. The MEPs
are typically organized in an orthogonal fashion across the muscle
fibers. The MEP regions can be seen as extending across the full
width of the muscles, passing through, but not limited to the region
commonly referred to as the muscle “belly” (Figures 1A–C). It is
worthwhile to note that some muscles do not have a “belly” region
but still have a clearly observable MEP region. This is the case
for acromiotrapezius, spinodeltoideus, and acromiodeltoideus. As
each muscle has its own shape, so too does its MEP region. In
most instances, the MEP regions are sinusoidal-like or V-shaped,
however they never appeared to form a straight line. For muscles
with multiple heads such as triceps and biceps brachii, the MEP
region is located in the common part of the muscle, not in the
heads. The thin and narrow muscles, such as those acting on the
wrist joint (extensor carpi radialis, extensor carpi ulnaris, flexor
digitorum profundus, and flexor carpi ulnaris) have their MEP
FIGURE 1 | Distribution of the motor end plate (MEP) regions for the
mouse forelimb. (A) Lateral view of the mouse forelimb after an
aceytlcholinesterase (AChE) histochemical reaction to reveal the location of
the MEPs. In this figure, the MEPs appear as black speckles traversing the
brown muscle fibers. From this lateral view, the following muscles can be
seen: (1) acromiotrapezius, (2) spinodeltoideus, (3) acromiodeltoideus, (4)
triceps brachii, (5) extensor carpi radialis, and (6) extensor carpi ulnari. The
insert shows a close up view of the MEPs from a portion of the triceps brachii
muscle. (B,C) Composite diagrams representing the location of the MEPs
from the lateral (B) and medial (C) view of the forelimb. The color-coded
forelimb muscles targeted are: acromiotrapezius (turquoise),
acromiodeltoideus (green), spinodeltoideus (dark blue), biceps brachii
(orange), triceps brachii (yellow), extensor carpi ulnaris (red), extensor carpi
radialis (magenta), flexor carpi ulnaris (light blue), and flexor digitorum
profundus (purple). The black dotted lines on each muscle are representative
locations of the MEP region.
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region located closer to the elbow joint rather than in the middle
of the muscle (Figures 1A–C).
FLUORO-GOLD LABELED MOTOR NEURONS
The intramuscular injections of FG gave rise to intense labeling
of motor neurons in proximity to the border between the gray
and white matter. Figure 2 is a photomicrograph of a right cervi-
cal cord to illustrate a typical column of labeled motor neurons.
On this figure, FG granulations are present within multiple motor
neuron somas and their processes.
DISTRIBUTION OF MOTOR NEURON COLUMNS SUPPLYING
INDIVIDUALLY TARGETED MUSCLES
A total of nine forelimb muscles were targeted with intramuscu-
lar injections of FG: three muscles acting on the shoulder joint
(acromiotrapezius, acromiodeltoideus, and spinodeltoideus), two
muscles acting on the elbow joint (biceps brachii and triceps
brachii), and four muscles acting on the wrist joint (extensor
carpi radialis, extensor carpi ulnaris, flexor carpi ulnaris, and flexor
digitorum profundus).
Acromiotrapezius
Acromiotrapezius, one of the muscles forming the trapezius mus-
cle group (Komárek, 2004; DeLaurier et al., 2008), can be seen
on the lateral aspect of the mouse forelimb (Figures 1A,B).
Acromiotrapezius is a thin but large muscle connecting the spinous
processes of vertebrae to the acromion process of the scapula. It
is involved in retraction, elevation, and depression of the scapula.
Six series of injections were performed along the MEP region of
acromiotrapezius, four of which gave rise to intense labeling in the
ventral horn of the cervical spinal cord. Data from these successful
series injections (n= 4) were included in the present analysis. Such
injections resulted in labeled motor neurons forming a column
spanning segments C2–C6 of the spinal cord (Figure 3A).
Acromiodeltoideus
Acromiodeltoideus, one of the two muscles comprising the del-
toid muscle group (Komárek, 2004; DeLaurier et al., 2008), is
located on the lateral aspect of the mouse forelimb (Figures 1A,B).
Acromiodeltoideus also acts on the glenohumeral joint. It is a small
triangular muscle located at the anterior point of the shoulder at
the junction of spinodeltoideus and biceps brachii (Figures 1A,B).
Six series of injections of FG were performed in acromiodeltoideus
and all six gave rise to intense labeling spanning segments C3–C7
of the cervical spinal cord (Figure 3B). Data from these successful
series of injections (n= 6) were included in the present analysis.
Spinodeltoideus
Together with acromiodeltoideus, spinodeltoideus belongs to the
deltoid muscle group (Komárek, 2004; DeLaurier et al., 2008).
Spinodeltoideus is a trapezoidal-shaped muscle present on the lat-
eral surface of the mouse forelimb (Figures 1A,B), immediately
adjacent to acromiotrapezius. As is the case with acromiotrapezius
and acromiodeltoideus, spinodeltoideus acts on the glenohumeral
joint. Five series of intramuscular injections were performed on
spinodeltoideus. Of these five series of injections, four series gave
rise to bright labeling of motor neurons spanning segments C3–
C6 of the cervical spinal cord (Figure 3C). Data from these four
FIGURE 2 | Photomicrograph of a DAPI-stained longitudinal section
through a right cervical spinal cord demonstrating a typical column of
Fluoro-Gold (FG)-labeled motor neurons. The insert displays a higher
magnification of motor neurons with clear FG granulations in the somas
and axons/dendrites. GM, gray matter; WM, white matter. The dashed line
represents the border between GM and WM.
successful injections (n= 4) were included in the present analysis.
It is worthwhile to mention that, in one case, two labeled motor
neurons were present in C7. These two motor neurons were not
taken into account in further analysis.
Biceps brachii
Biceps brachii is located on the ventral aspect of the upper forelimb
(Figures 1A–C) (Komárek, 2004; DeLaurier et al., 2008). The two
proximal heads of biceps brachii unite to form one distal muscle
mass that flexes the elbow joint. A total of six series of intramuscu-
lar injections of FG were performed into biceps brachii and all of
the series gave rise to intense labeling of motor neurons between
segments C3 and C7 of the spinal cord (Figure 3D). Data from
these six successful series of injections (n= 6) were included in
the present analysis.
Triceps brachii
Triceps brachii is located on the dorsal aspect of the upper fore-
limb (Figures 1A–C) (Komárek, 2004; DeLaurier et al., 2008).
Similarly to biceps brachii, the three proximal heads of triceps
brachii join to form one belly that extends the elbow joint. A total
of six series of intramuscular injections of FG were performed
into triceps brachii, four series of which resulted in intense label-
ing of a motor neuron column that spans segments C4–T1 of the
spinal cord (Figure 3E). Data from these four series of injections
(n= 4) were included in the present analysis. In one series case,
however, three labeled motor neurons were present in rostral T1.
These three motor neurons were not taken into account in further
analysis.
Extensor carpi ulnaris
Extensor carpi ulnaris is one of the two muscles targeted in
the present investigation that extends the wrist joint (Komárek,
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FIGURE 3 | Composite diagram illustrating the distribution of labeled
motor neurons from each targeted muscle. Each black dot represents one
labeled motor neuron and each columnar-shaped data set represents the
FG-labeling observed after intramuscular injections in one muscle. (A)
Acromiotrapezius, (B) acromiodeltoideus, (C) spinodeltoideus, (D) biceps
brachii, (E) triceps brachii, (F) extensor carpi ulnaris, (G) extensor carpi
radialis, (H) flexor carpi ulnaris, and (I) flexor digitorum profundus. Spinal cord
levels are indicated in the white matter on the right hand side of each
diagram. Each cervical/thoracic spinal cord segment is demarcated by dashed
lines. These lines correspond to the halfway point between two nerve roots.
2004; DeLaurier et al., 2008). Extensor carpi ulnaris is a thin and
shallow muscle located on the dorsal aspect of the distal forelimb
(Figures 1A,B). Overall, there were four series of intramuscular
injections performed in extensor carpi ulnaris, with three series
giving rise to intense motor neuron labeling located between seg-
ments C2 and C8 of the cervical spinal cord (Figure 3F). Data from
these three successful series of injections (n= 3) were included in
the present analysis. In one case, however, one labeled motor neu-
ron was present in caudal C2. This motor neuron was not taken
into account in further analysis.
Extensor carpi radialis
Together with extensor carpi ulnaris, extensor carpi radialis, which
is located on the dorsal part of the mouse distal forelimb, extends
the wrist joint (Figures 1A–C) (Komárek, 2004; DeLaurier et al.,
2008). Extensor carpi radialis is comprised of a smaller brevis and
a larger longus compartments; however, both parts were targeted
together. A total of six series of intramuscular injections of FG
were performed into extensor carpi radialis. Of these six series, five
series of injections gave rise to consistent labeling of motor neu-
rons spanning cervical segments C2–C7 (Figure 3G). Data from
these five injections (n= 5) were included in the present analysis.
Flexor carpi ulnaris
Flexor carpi ulnaris, a flexor muscle that acts on the wrist joint, is
located on the ventral aspect of the distal part of the mouse fore-
limb (Figure 1C) (Komárek, 2004; DeLaurier et al., 2008). A total
of four series of intramuscular injections of FG were performed in
flexor carpi ulnaris. Of these injections, three gave rise to intense
labeling of motor neurons forming a column between segments
C6 and T1 of the spinal cord (Figure 3H). Data from these three
injections (n= 3) were included in the present analysis.
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Flexor digitorum profundus
As is the case for flexor carpi ulnaris, flexor digitorum profundus
is a wrist flexor located on the ventral aspect of the mouse distal
forelimb (Figure 1C) (Komárek, 2004; DeLaurier et al., 2008). A
total of four series of intramuscular injections were performed
into flexor digitorum profundus and all four series gave rise to
intense motor neuron labeling between segments C5 and T1 of
the spinal cord (see Figure 3I). Data from these four injections
(n= 4) were included in the present analysis.
PARTIAL TARGETING OF THE MOTOR END PLATE REGION IN TRICEPS
BRACHII
Figure 4A is a schematic representation of the portions of the MEP
region of triceps brachii that were selectively targeted with FG.
These regions are the anterior and posterior halves and the center
of the MEP region. Figure 4B shows the distribution of labeled
motor neurons resulting from these partial injections. Injections
throughout the full length of the MEP region gave rise to columns
of labeled motor neurons that extends from segment C4 through
the rostral part of C8. In comparison, the partial targeting of the
MEP region gave rise to correspondingly partial labeling of triceps
brachii’s motor neuron column. More specifically, the targeting of
the anterior portion of the MEP region resulted in the labeling of
motor neurons forming a column mainly spanning segments C4–
C5. Conversely, FG injections limited to the posterior part of the
MEP region for triceps brachii gave rise to a column of positively
labeled motor neurons, the bulk of which was confined within
segments C7 and the rostralmost aspect of C8. Moreover, single
injections of FG in the center of the MEP region produced labeling
in fewer motor neurons mainly confined to segment C7. Further-
more, the application of FG onto the external surface of triceps
brachii’s fascia resulted in a negligible number of labeled motor
neurons.
OVERALL ORGANIZATION OF THE MOTOR NEURON COLUMNS
SUPPLYING THE MOUSE FORELIMB
Figure 5 is a diagrammatic representation of the motor neuron
columns for all muscles targeted in the present investigation. On
the rostro-caudal axis, these columns of motor neurons encompass
segments C2–T1 of the mouse spinal cord (Figure 5A). As shown
in this figure, a great amount of overlap can be observed between
these motor neuron columns. Motor neuron columns innervating
the muscles acting on the glenohumoral joint (i.e., acromio-
trapezius, acromiodeltoideus, and spinodeltoideus) extend from
segments C2 to C7 whereas the motor neuron columns supply-
ing the muscles acting on the elbow joint (i.e., biceps brachii
and triceps brachii) span segments C3–C8. Moreover, the exten-
sor (i.e., extensor carpi radialis, extensor carpi ulnaris) and flexor
(i.e., flexor carpi ulnaris and flexor digitorum profundus) muscles
acting on the wrist joint are innervated by motor neuron columns
spanning segments C2–C8 and C5–T1, respectively. Overall, there
is a topographical relationship, on the rostro-caudal axes, between
the different muscles targeted in the present analysis and the motor
neuron columns that innervate them. This relationship is such
that the proximal-most muscles (e.g., acromiotrapezius) are inner-
vated by motor neuron columns located in the rostral segments
FIGURE 4 | Selective Fluoro-Gold (FG) targeting of the motor end plate
region in triceps brachii and the resulting labeling in the spinal motor
neurons. (A) Schematic representation of the motor end plates (MEPs)
selectively targeted on the triceps brachii muscle. The green and red dots
represent the anterior and posterior halves of the entire MEP region,
respectively. The blue dots indicate the location of a bolus injection of FG in
the belly of the muscle. The double-headed arrow indicates the
antero-posterior direction. (B) Distribution of labeled motor neurons
resulting from selective MEP injections of FG as indicated in (A). The black
motor neuron column is taken from Figure 3E and represents the typical
labeling observed after full-length MEP injections in triceps brachii. The red
motor neuron column was obtained after FG injections along the posterior
half of the MEP region. The green motor neuron column was obtained after
FG injections along the anterior half of the MEP region. The blue motor
neuron column was obtained after FG bolus injections in the belly of triceps
brachii. The magenta “column” was obtained after application of FG onto
the external surface of the fascia over triceps brachii. Each cervical/thoracic
spinal cord segment is demarcated by dashed lines. These lines correspond
to the halfway point between two nerve roots.
of the cervical spinal cord whereas the distal-most muscles (e.g.,
flexor carpi ulnaris) are supplied by columns located more cau-
dally. Exceptions to this organizational scheme are the motor
neuron columns for the two wrist extensors, namely extensor carpi
radialis and extensor carpi ulnaris. Although these muscles are
located in the distal part of the forelimb, they are supplied by
motor neuron columns located in rostral segments of the spinal
cord. Figure 5B shows the motor neuron columns in the trans-
verse plane at spinal cord levels C3, C5, and C7. On this plane,
the columns of motor neurons also exhibit a high level of overlap
with each other. Overall, there is a dorso-ventral topographical
relationship between the muscles targeted in the present investi-
gation and the motor neurons that supply them. This relationship
is such that the proximal (e.g., acromiotrapezius) and distal mus-
cles (e.g., flexor carpi ulnaris) are innervated by motor neuron
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FIGURE 5 | Color-coded schematic map of the motor neuron columns
innervating the Fluoro-Gold targeted forelimb muscles. The color
schemes remain consistent with that of Figures 1B,C. (A) Rostro-caudal
map of the motor neuron columns innervating the targeted forelimb
muscles. These columns were obtained by combining plots from Figure 3.
The nerve root exit points represent the halfway point between spinal cord
segments throughout C2–T1. (B) Dorso-ventral and medio-lateral map of
the motor neuron columns innervating the targeted forelimb muscles for
spinal cord segments C3, C5, and C7. The gray matter contours were
adapted from Watson et al. (2009).
columns located ventrally and dorsally, respectively, within the
ventral horn spinal cord.
DISCUSSION
We have recently targeted the entire MEP region of several muscles
of the rat forelimb with retrograde tracers (Tosolini and Morris,
2012). The results of this analysis showed that the motor neu-
ron columns that supply these muscles extend over more cervical
spinal cord segments and display greater overlap with one another
than formerly reported. The aim of the present investigation was
to transfer this knowledge to the species of choice for the design of
genetically engineered models of motor dysfunction, namely the
mouse. The main outcomes of this study are first, the production
of a detailed map of the motor end plate region for nine mus-
cles of the mouse forelimb. This map was subsequently used as
a guide to target the entire motor end plate region of these mus-
cles with FG. The second main outcome is the characterization
of the topographical organization that exists between the mouse
forelimb muscles and the motor neuron columns that innervate
them.
MOTOR END PLATE ANALYSIS
To our knowledge, the present study is the first description of the
MEP regions in the mouse forelimb. This analysis revealed that the
MEP region for the different muscles targeted is located orthogo-
nally to the direction of the muscle fibers. It is noteworthy that the
MEP region is not consistently located within the fleshy part of a
muscle (i.e., the muscle “belly”). Moreover, some muscles such as
acromiotrapezius, spinodeltoideus, and acromiodeltoideus are flat
and therefore do not have such a fleshy region. In these muscles
as well as in triceps and biceps brachii, the MEP region traverses
the entire width of the muscle (see Figure 1). The thin and narrow
muscles, such as extensor carpi radialis, extensor carpi ulnaris,
flexor digitorum profundus, and flexor carpi ulnaris have a fleshy
part where the MEP regions are located. However, in these muscles,
the so-called “belly” is not located in the center of the muscle but
closer to the elbow joint. In most cases, the MEP region does not
form a straight band. Rather, MEPs often exhibit a sinusoidal-like
curve or are V-shaped. These findings are consistent with previous
MEP characterization in the rat forelimb (Tosolini and Morris,
2012).
Fluoro-Gold was also injected along partial aspects of the MEP
region in triceps brachii (see Figure 4A). The rostro-caudal extent
of the labeling obtained from these partial MEP injections was then
compared with that resulting from injections along the full length
of the MEP region (see Figure 4B). Injections of FG restricted
to the anterior half of the MEP region gave rise to a column
of labeled motor neurons spanning only the rostral part of the
columns of neurons obtained after complete MEP region injec-
tions. Conversely, FG injections restricted to the posterior half of
the MEP region in triceps brachii produced a column of labeled
motor neurons spanning only the caudal half of the column of
motor neurons obtained after complete MEP region injections.
Interestingly, combined labeling from the anterior and posterior
MEP injections resulted in a column of similar span to that pro-
duced from the injections of the complete MEP region. These
data suggest the existence of a MEP/motor neuron topographical
relationship, although more data points need to be generated to
confirm this a priori interesting finding. Should such organization
be confirmed for triceps brachii, the MEP/motor neuron rela-
tionship will have to be established for the other muscles of the
mouse forelimb. Injections selectively targeting the belly of triceps
brachii were also performed (see Figure 4). As compared with the
complete MEP data, these injections gave rise to shorter columns
with substantially less FG-positive motor neurons. Together, these
data can explain, at least partly, why targeting the entire MEP
region with FG gave rise to labeled motor neurons spanning more
spinal cord segments than recently observed (e.g., Bácskai et al.,
2013a).
METHODOLOGICAL CONSIDERATIONS
In the present analysis, functionally diverse muscle groups that
act on the three major joints of the forelimb were targeted with
FG, namely the shoulder, elbow, and wrist. Superficial muscles
of the mouse forelimb were selected for this tract-tracing exper-
iment because these muscles are easily accessible. Indeed, the
deeper muscles of the forelimb require a significant amount of
dissection before they can be exposed and subjected to neu-
ronal tracer injections, hence creating a risk for contamina-
tion of the tracers to surrounding muscles. It is our opin-
ion that the superficial muscles of the forelimb have greater
translational relevance than the deeper ones, as they are more
likely to be the target in clinical trials involving somatic gene
therapy.
In our hands, FG has proven to be a reliable and robust retro-
grade tracer that produces intense labeling of the neuronal somas
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and processes, therefore allowing for easy identification and direct
count of motor neurons (see Figure 2). Importantly, unlike some
other neuronal tracers, FG does not have the tendency to leak
out of the cells (Schmued and Fallon, 1986). Yet, leakage has been
recently reported after intramuscular injections of FG in the mouse
forelimb (Bácskai et al., 2013a). It is important to note that mus-
cle fasciae consist of tough layers of fibrous connective tissue that
act as a natural barrier to tracer leakage (Haase and Hrycyshyn,
1986). In the present study, great care was taken to leave the mus-
cle fasciae intact, aside from the penetrations of the ultra-thin
micropipettes. It is also worth mentioning that the outermost
aspect of the fasciae (i.e., the fasciae that can be readily visual-
ized once the skin over the muscle of interest is cut open) was
difficult to puncture even with the sharpest glass micropipettes.
As the innermost fasciae (i.e., the fasciae that cover the innermost
part of the muscles) would offer the same resistance against punc-
ture, we are confident that the minute amount of tracer injected
did not contaminate the deep muscles underlying those of interest.
Additionally, the exposed region was routinely wiped off imme-
diately after each injection in order to remove any tracer that
may have seeped out. Special care was also taken to ensure that
the blood vessels surrounding the muscles were not perforated.
Taken together, these precautions ensured that insignificant spuri-
ous labeling was generated in the present investigation. However,
leakage of the tracer to adjacent muscles cannot be entirely ruled
out. To investigate the possibility that, despite these extensive pre-
cautions, some tracer might have been taken up by non-targeted
surrounding muscles, FG was directly applied onto the external
fascia covering triceps brachii (see Figure 4B). The result of such
application of FG resulted in negligible labeling, therefore con-
firming that, at least in our hands, spurious labeling was not
significant.
Overall, all injections of FG in the same muscles resulted in
similar labeling for each animal. However, some variability was
observed, in the extent, on the rostro-caudal axes, of the motor
neuron column (see Figure 3). The same observation has been
reported in previous tract-tracing investigations of the organiza-
tion of motor neurons supplying the skeletal muscles (Hollyday,
1980; McHanwell and Biscoe, 1981; Nicolopoulos-Stournaras and
Iles, 1983; Vanderhorst and Holstege, 1997; McKenna et al., 2000;
Coonan et al., 2003; Tosolini and Morris, 2012; Bácskai et al.,
2013a,b). This variability could be due to intraspecies differences
with regard to the overall number of motor neurons innervat-
ing a muscle, a phenomenon that, in turn, influences the length
and/or spatial distribution of the motor neuron columns. Inter-
estingly, we also found slight differences in spatial distribution
of motor neuron columns within the same animal, i.e., between
homologous muscles in the left and right forelimbs. It is possible
that this finding reflects forelimb use preference (i.e., handed-
ness). Forelimb preference when reaching is well documented
in the rat (Gharbawie et al., 2007; Alaverdashvili et al., 2008;
Alaverdashvili and Whishaw, 2010; Morris et al., 2011); how-
ever, it is still a matter of debate in the mouse (Neveu et al.,
1988; Takeda and Endo, 1993; Waters and Denenberg, 1994; Bid-
dle and Eales, 1996; Bulman-Fleming et al., 1997). In the present
study, forelimb use preference was not determined prior to the
delivery of neuronal tracer. Thus, whether forelimb use preference
affects the distribution of the motor neuron columns remains
to be investigated. On the other hand, one cannot rule out that
there could have been differences in the uptake of FG across
different injections targeting the same muscle. Indeed, although
great care was taken to minimize inter-injection variability, the
uptake of FG could have been suboptimal in some cases. In
these instances, the number of labeled motor neurons can actu-
ally be considered as an underestimation of the actual population
(Nicolopoulos-Stournaras and Iles, 1983; Tosolini and Morris,
2012).
TRANSLATIONAL RELEVANCE
Neurological conditions that affect lower motor neurons are
among the most debilitating motor disorders. Genetically based
mouse models are currently available for conditions that directly
affect the output of spinal cord motor neurons on the skeletal
musculature. In particular, these include models of amyotrophic
lateral sclerosis, i.e., the SOD-1-G93A and A315T-TDP-43 strains
(Jackson Laboratory, Bar Harbor, ME, USA) (Kaspar et al., 2003;
Ishiyama et al., 2004; Turner et al., 2009; Wegorzewska et al.,
2009; Towne et al., 2010; Xu et al., 2010; Guo et al., 2011;
Riboldi et al., 2011). Likewise, models of Duchenne’s muscu-
lar dystrophy, i.e., the various mdx strains (Jackson Laboratory,
Bar Harbor, ME, USA) (Kimura et al., 2010; Pratt et al., 2013)
and of SMA, i.e., the SMN−/− strain (Hsieh-Li et al., 2000)
are also available. Mice with these above-mentioned mutations
display a typical motor phenotype with upper and lower limb
deficits.
Several treatment strategies have been designed in an attempt
to reverse the motor phenotype in these mutant mice. For instance,
both pharmaceutical and cell-based therapies have been per-
formed through different routes of administration (Raoul et al.,
2005; Henriques et al., 2011; Teng et al., 2012). These therapeutic
approaches have been shown to slow the progression of the motor
phenotype, to increase lifespan of the affected animals but are
yet to eradicate these conditions. Targeted delivery of therapeutic
agents to motor neurons for the treatment of ALS-like phenotypes
has also been achieved via intramuscular injections and the ensu-
ing retrograde transport along the peripheral nerve (e.g., Kaspar
et al., 2003; Wu et al., 2009; Calvo et al., 2011). Intramuscular
injection and retrograde delivery of therapeutic molecules is a
minimally invasive surgical procedure and, in combination with
viral vectors, offers promising potential for translational gene ther-
apy aiming at the restoration of motor function (Baumgartner
and Shine, 1998; Giménez y Ribotta et al., 1998; Kaspar et al.,
2003; Nakajima et al., 2008; Towne et al., 2010; Uchida et al., 2012;
Benkhelifa-Ziyyat et al., 2013). The present anatomical investiga-
tion has clearly shown that targeting the full width of the muscles’
MEP region can maximize the success of somatic delivery of ther-
apeutic molecules to spinal cord motor neurons. Thus, knowledge
regarding the precise anatomical relationship between the differ-
ent muscles of the mouse forelimb and the location of: (1) their
MEP region and (2) the spinal cord motor neuron columns that
supply them will prove to be valuable tools to further investigate
new treatment for ALS and other related motor disorders.
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